These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36204234)

  • 1. AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/
    Huang L; Ye Q; Lan C; Wang X; Zhu Y
    Front Pharmacol; 2022; 13():990401. PubMed ID: 36204234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway.
    Huang L; Wei Z; Wang X; Lan C; Zhu Y; Ye Q
    Biochem Pharmacol; 2022 Dec; 206():115340. PubMed ID: 36347274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPPB modulates apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling.
    Sun L; Dong Y; Zhao J; Yin Y; Tong B; Zheng Y; Xin H
    Int J Mol Med; 2018 Mar; 41(3):1331-1338. PubMed ID: 29286070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane modulates TGFβ2-induced conjunctival fibroblasts activation and fibrosis by inhibiting PI3K/Akt signaling.
    Liu HR; Xia ZY; Wang NL
    Int J Ophthalmol; 2020; 13(10):1505-1511. PubMed ID: 33078098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Suppression of the Chloride Channel 2 Suppressed TGF-β1-Induced Proliferation, Collagen Synthesis, and Collagen Gel Contraction Mediated by Conjunctival Fibroblasts.
    Sun L; Cui R; Meng H; Liu X; Liu X; Lu Y; Liu K; Jia L; Zheng Y
    Ophthalmic Res; 2021; 64(5):775-784. PubMed ID: 32235125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy.
    Igarashi N; Honjo M; Aihara M
    Exp Eye Res; 2021 Feb; 203():108421. PubMed ID: 33359326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFβ1-Induced Fibrotic Responses of Conjunctival Fibroblasts through the Wnt/β-Catenin/CRYAB Signaling Pathway.
    Wang X; Chen K; Yao Y; Lin Y; Yang J; Zhu Y; Zhou B
    Am J Pathol; 2024 Sep; 194(9):1764-1779. PubMed ID: 38879081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery.
    Cheng WS; Chen CL; Chen JT; Lin LT; Pao SI; Chen YH; Lu DW
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32993110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All‑trans‑retinoic acid modulates TGF‑β‑induced apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling.
    Liang L; Wang X; Zheng Y; Liu Y
    Mol Med Rep; 2019 Sep; 20(3):2929-2935. PubMed ID: 31322252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forkhead domain inhibitory-6 attenuates subconjunctival fibrosis in rabbit model with trabeculectomy.
    Lan C; Tan J; Tang L; Liu G; Huang L; Luo X; Zhou L; Zhu Y; Liu X; Fan N
    Exp Eye Res; 2021 Sep; 210():108725. PubMed ID: 34375589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells.
    Kim HJ; Min A; Im SA; Jang H; Lee KH; Lau A; Lee M; Kim S; Yang Y; Kim J; Kim TY; Oh DY; Brown J; O'Connor MJ; Bang YJ
    Int J Cancer; 2017 Jan; 140(1):109-119. PubMed ID: 27501113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of latent transforming growth factor-beta binding protein-1 and TGF beta 1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts.
    Saika S; Yamanaka O; Baba Y; Kawashima Y; Shirai K; Miyamoto T; Okada Y; Ohnishi Y; Ooshima A
    Graefes Arch Clin Exp Ophthalmol; 2001 Mar; 239(3):234-41. PubMed ID: 11405075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy.
    Shi H; Wang H; Fu S; Xu K; Zhang X; Xiao Y; Ye W
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1478-1486. PubMed ID: 28273314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA).
    Futakuchi A; Inoue T; Fujimoto T; Kuroda U; Inoue-Mochita M; Takahashi E; Ohira S; Tanihara H
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2421-2429. PubMed ID: 28448670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TβR II-targeted aptamer S58 prevents fibrosis after glaucoma filtration surgery.
    Li X; Leng Y; Li X; Wang Y; Luo P; Zhang C; Wang Z; Yue X; Shen C; Chen L; Liu Z; Shi C; Xie L
    Aging (Albany NY); 2020 May; 12(10):8837-8857. PubMed ID: 32452828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
    Jung KH; Ryu YL; Lee HS; Lee H; Son MK; Yan HH; Hong SW; Ryu JK; Hong S; Suh JK; Hong SS
    Int J Oncol; 2013 Jun; 42(6):2001-8. PubMed ID: 23588860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration.
    Fròsina G; Profumo A; Marubbi D; Marcello D; Ravetti JL; Daga A
    Radiat Oncol; 2018 Apr; 13(1):76. PubMed ID: 29685176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.
    Kulasekaran P; Scavone CA; Rogers DS; Arenberg DA; Thannickal VJ; Horowitz JC
    Am J Respir Cell Mol Biol; 2009 Oct; 41(4):484-93. PubMed ID: 19188658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of TGF-beta-induced tissue transglutaminase expression by PI3K-Akt pathway activation in human subconjunctival fibroblasts.
    Jung SA; Lee HK; Yoon JS; Kim SJ; Kim CY; Song H; Hwang KC; Lee JB; Lee JH
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):1952-8. PubMed ID: 17460246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
    Nam AR; Jin MH; Park JE; Bang JH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):1167-1179. PubMed ID: 30514066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.